Since the identification of RKIP as a candidate suppressor of PC metastasis by Fu et al. in 2003 [88], accumulative research reinforces RKIP as a tumor suppressor and metastatic suppressor not only in PC but also in other cancer types [95]. Here, PEBP1 is linked to neoplasm.